82117-28-0 Usage
Molecular structure
A compound with 14 carbon atoms, 17 hydrogen atoms, and 1 nitrogen atom arranged in a specific configuration.
Classification
A member of the isoquinoline family of chemical compounds.
Pharmaceutical properties
Known for its potential use in the development of drugs and treatment of various central nervous system disorders.
Research applications
Frequently used in research, particularly in the field of neuroscience and the study of neurological disorders.
Therapeutic potential
Has been studied for its potential as a therapeutic agent for conditions such as Parkinson's disease and other neurological disorders.
Chemical interactions
Valuable for investigating the interactions of neurotransmitters and receptors in the brain.
Medication development
Used for developing new and more effective medications for the treatment of various neurological conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 82117-28-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,1,1 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 82117-28:
(7*8)+(6*2)+(5*1)+(4*1)+(3*7)+(2*2)+(1*8)=110
110 % 10 = 0
So 82117-28-0 is a valid CAS Registry Number.
82117-28-0Relevant articles and documents
Preparation of N1-alkyl- and N1,N1-dialkylisoquinoline-1,3-diamines and 1-alkyl- and 1-phenylisoquinolin-3-amines from the reaction of α-cyano- o-tolunitrile with lithium amides, alkyllithiums, and phenyllithium
Wang, Anlai,Zhang, Hongming,Biehl, Edward R.
, p. 291 - 300 (2000)
A facile, one-step synthesis of the titled compounds from the reaction of α-cyano-o-tolunitrile with LiNHR, LiNRR', RLi, or PhLi is described. A mechanism is presented in which α-cyano-o-tolunitrile is first converted quantitatively to its ketenimine carb
